Northeast Financial Consultants’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Hold |
5,574
| – | – | 0.02% | 188 |
|
|
2025
Q1 | $562K | Hold |
5,574
| – | – | 0.02% | 184 |
|
|
2024
Q4 | $498K | Hold |
5,574
| – | – | 0.02% | 192 |
|
|
2024
Q3 | $467K | Buy |
5,574
+39
| +0.7% | +$3.27K | 0.02% | 199 |
|
|
2024
Q2 | $426K | Sell |
5,535
-995
| -15% | -$76.6K | 0.02% | 202 |
|
|
2024
Q1 | $447K | Hold |
6,530
| – | – | 0.02% | 206 |
|
|
2023
Q4 | $378K | Hold |
6,530
| – | – | 0.02% | 212 |
|
|
2023
Q3 | $345K | Hold |
6,530
| – | – | 0.02% | 211 |
|
|
2023
Q2 | $353K | Hold |
6,530
| – | – | 0.02% | 215 |
|
|
2023
Q1 | $327K | Hold |
6,530
| – | – | 0.02% | 240 |
|
|
2022
Q4 | $302K | Hold |
6,530
| – | – | 0.02% | 241 |
|
|
2022
Q3 | $253K | Hold |
6,530
| – | – | 0.02% | 285 |
|
|
2022
Q2 | $243K | Hold |
6,530
| – | – | 0.02% | 284 |
|
|
2022
Q1 | $289K | Hold |
6,530
| – | – | 0.02% | 309 |
|
|
2021
Q4 | $277K | Hold |
6,530
| – | – | 0.02% | 293 |
|
|
2021
Q3 | $283K | Hold |
6,530
| – | – | 0.02% | 292 |
|
|
2021
Q2 | $279K | Hold |
6,530
| – | – | 0.02% | 295 |
|
|
2021
Q1 | $252K | Hold |
6,530
| – | – | 0.02% | 292 |
|
|
2020
Q4 | $235K | Hold |
6,530
| – | – | 0.02% | 288 |
|
|
2020
Q3 | $250K | Hold |
6,530
| – | – | 0.02% | 253 |
|
|
2020
Q2 | $229K | Buy |
+6,530
| New | +$229K | 0.02% | 249 |
|
|
2019
Q4 | – | Sell |
-7,295
| Closed | -$297K | – | 311 |
|
|
2019
Q3 | $297K | Hold |
7,295
| – | – | 0.03% | 246 |
|
|
2019
Q2 | $314K | Hold |
7,295
| – | – | 0.03% | 235 |
|
|
2019
Q1 | $280K | Buy |
+7,295
| New | +$280K | 0.03% | 238 |
|